Condition Overview

Lupus, SLE

For people living with systemic lupus erythematosus who ask what supportive care can and cannot do.

Cellular artwork for Lupus, SLE Personalized review, grounded in your health history.

Understanding lupus and SLE

Systemic lupus erythematosus, or lupus, is a chronic autoimmune disease in which the immune system attacks the body’s own tissues. It can affect the skin, joints, kidneys, lungs, heart, blood cells, and nervous system. Symptoms and severity vary, and people may experience periods of flare and remission.

Lupus requires ongoing care, usually led by a rheumatologist, with treatment selected according to organ involvement and disease activity. Cellular and regenerative approaches are being studied, but they are not established general care for lupus. Nothing discussed here replaces immune-modifying medication, laboratory monitoring, or urgent evaluation of a flare.

Our consultation reviews your diagnosis, organ involvement, current treatment, recent stability, and goals. A licensed provider explains the limits of the evidence and decides whether any supportive assessment is appropriate. Many people with active or complex disease will not be eligible.

Do not wait for a consultation if you are unwell now. Chest pain, shortness of breath, a seizure, new confusion, a sudden severe headache, or new weakness on one side need emergency care now: call 911. A fever while you are taking immune-modifying medication, blood in your urine, significant new swelling, or a flare that is getting worse day by day need same-day contact with your rheumatologist or an urgent care service. A flare is assessed by the team managing your disease, not here.

Potential Benefits

A lupus consultation may help you:

  • A review of your diagnosis, your organ involvement, and your current disease activity
  • A clear account of what cell-based research has and has not established in lupus
  • Screening against the factors that make supportive care inappropriate
  • Questions to discuss with your rheumatologist
  • A direct answer, which for many people with lupus will be that nothing here is appropriate

Who May Benefit

A lupus assessment may make sense for people including:

  • Adults with confirmed lupus who remain under rheumatology care
  • People whose disease and medication plan are clinically stable
  • Individuals seeking a careful explanation of emerging research
  • People willing to share recent laboratory and medication information
  • Adults who understand that lupus treatment must not be interrupted

Therapies a Provider May Consider

Every option is reviewed individually after your history, current care, and goals are understood.

What the Research Looks At

Lupus is a complex autoimmune disease with established specialist management. Cellular research is ongoing, but it does not support replacing standard treatment. These references provide condition guidance, regulatory context, and registered-study information.

  1. Lupus (Systemic Lupus Erythematosus) National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH
  2. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes U.S. Food and Drug Administration
  3. Registered clinical trials related to Systemic Lupus Erythematosus ClinicalTrials.gov, U.S. National Library of Medicine

Start With an Assessment

Every visit begins with a consultation and a medical screening. A licensed provider decides what, if anything, is appropriate for you.

Terms you may hear when discussing lupus

Lupus is followed closely with blood and urine tests, and the vocabulary reflects that. These are the terms most likely to appear in your rheumatology records and in the screening here.

  • Systemic lupus erythematosus. The full name of the condition, usually shortened to SLE or lupus. “Systemic” means it can involve many organs, which is why the same diagnosis looks very different from one person to the next.
  • Flare. A period of increased disease activity, with new or worsening symptoms. Flares are assessed and managed by the team treating your lupus, and a flare in progress is a reason a provider here will not proceed.
  • ANA and anti-dsDNA. Antibody blood tests used in diagnosing lupus and, for anti-dsDNA in particular, in monitoring activity over time. Your rheumatologist reads them alongside complement levels and other markers.
  • Lupus nephritis. Kidney involvement, one of the more serious forms of the disease. It is monitored with urine and blood tests and treated with specific immune-modifying medication.

A licensed provider reviews your diagnosis, organ involvement, current treatment, recent stability and goals before deciding whether any supportive assessment is appropriate alongside your rheumatologist’s care. Nothing offered is a treatment for lupus, and many people with active or complex disease will not be eligible.

Related conditions in this care area: Rheumatoid Arthritis, Chronic Fatigue Syndrome, ME-CFS and Healthy Aging and General Wellness. Back to Longevity and Vitality.

Lupus, SLE

Frequently Asked Questions

No. Nothing offered here is a cure or an approved treatment for systemic lupus erythematosus. The purpose of the consultation is to review your history, explain the limits of current research, and decide whether any supportive assessment is appropriate.
No. Immune-modifying medication, laboratory monitoring, and the management of any flare stay with your rheumatologist. This consultation sits alongside that care and does not replace it, and nothing discussed here is a reason to stop, reduce, or delay lupus treatment.
You share intake information, your current medication, and recent laboratory results, then complete a medical screening. A licensed provider reviews your organ involvement, your disease activity, and your goals. Only after that review can the provider decide whether any next step is appropriate, and active or complex disease usually means the answer is no.
A licensed provider makes that decision after reviewing your history and screening information. Not everyone is eligible, and being told that no further step is appropriate is a normal outcome of an honest assessment.
Hitech Regen serves Southern California. Availability and suitability are discussed during the consultation before any visit is scheduled.
Cost is discussed after a licensed provider determines whether anything is appropriate to consider. We do not quote a condition-specific plan before the assessment.
No. Lupus medication is prescribed, monitored and adjusted by a rheumatologist. We do not change prescribed medication. Any change is a conversation with your rheumatologist, not with us.
Yes, and you should say so at intake. Being immunosuppressed changes what is safe to consider, and it is one of the things a licensed provider weighs during the medical screening.
Lupus nephritis is managed by your rheumatologist and nephrologist. Tell us if you have renal involvement, and expect the provider to want those records before discussing any next step.
Book the consultation if you want the conversation, but tell us you are flaring. An active flare is managed by your rheumatologist, and it is relevant to whether the provider considers anything here appropriate at that moment.
Book a Consultation